Friday
SESSION 77: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS WITH MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
Location: Grand Ballroom East, 3rd Floor
Moderators:Frank J. Veith, MD / Klaus D. Mathias, MD / Sumaira Macdonald, MD, PhD  
SESSION 77 SCHEDULE
MESH COVERED STENTS
7:53 AM - 7:58 AM Long-Term Results Of Micromesh Stents Show Their Value In Carotid Artery Stenting (CAS): Are There Limitations: Do The Differences In The 3 Micromesh Stents Matter
  Presenter(s):Piotr Musialek, MD, DPhil / Max Amor, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
7:59 AM - 8:04 AM Update On Carotid And Other Uses Of MicroNet-Covered Stents (C-Guard) In High-Risk Lesions And Aneurysms: What Are The Long-Term Outcomes And Are There Downsides
  Presenter(s):Piotr Musialek, MD, DPhil / Stefan Mueller-Huelsbeck, MD  
Location: Grand Ballroom East, 3rd Floor
8:05 AM - 8:10 AM New Multicenter Data Showing The Long-Term Value Of The C-Guard MicroNet Mesh Covered Stent For CAS In High Risk Carotid Lesions (Thrombotic, Calcified And Symptomatic) From The FLOW-GUARD And Other Trials
  Presenter(s):D. Christopher Metzger, MD  / Piotr Musialek, MD, DPhil  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:11 AM - 8:16 AM Results From A Multicenter Italian Study Of The C-Guard Micromesh Stent For CAS: Advantages And Complications
  Presenter(s):Francesco Speziale, MD / Gianmarco de Donato, MD / Ashraf Mansour, MD / Pasqualino Sirignano, MD / Carlo Setacci, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
TCAR RELATED TOPICS
8:17 AM - 8:22 AM TCAR Versus Transfemoral CAS (TFCAS) And CEA (Carotid Endarterectomy): From Propensity Matched VQI Studies: What Do They Show Re Stroke, Death And Complication Rates: TCAR Approval Should Be Expanded To Non-High-Risk Patients
  Presenter(s):Marc L. Schermerhorn, MD / Mahmoud B. Malas, MD, MHS  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:23 AM - 8:28 AM Real World Single Center (100-Patient Experience) With TCAR: How And Why 30-Day And One Year Outcomes Differ From Those In ROADSTER 1 And ROADSTER 2
  Presenter(s):Zach AbuRahma, DO / Ali F. AbuRahma, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:29 AM - 8:34 AM DEBATE: TCAR Is Better Than TFCAS And Brachial/Radial Access For CAS: TCAR Approval Should Be Expanded To Non-High-Risk Patients
  Presenter(s):Mahmoud B. Malas, MD, MHS / Marc L. Schermerhorn, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:35 AM - 8:40 AM DEBATE: Not So: TCAR Is No Better And Is More Costly Than TFCAS And Brachial/Radial Access CAS If One Has Appropriate Skills
  Presenter(s):D. Christopher Metzger, MD  / William A. Gray, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:41 AM - 8:46 AM Adjunctive EEG Can Help With TCAR And Decrease The Stroke Rate: When And How
  Presenter(s):Todd R. Vogel, MD, MPH  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:47 AM - 8:52 AM DEBATE: Based On Data To Date Including 1-Year Results From ROADSTER 2, TCAR Should Replace CEA In Most Cases: When Is TCAR Contraindicated
  Presenter(s):Vikram S. Kashyap, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:53 AM - 8:58 AM DEBATE: Not So: CEA Is Routinely Better Than TCAR And Remains The Gold Standard: It Should Be Used In Most Cases Requiring Invasive Treatment
  Presenter(s):Michel Makaroun, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:59 AM - 9:07 AM Panel Discussion
9:07 AM - 9:17 AM Break Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 77
previous next